Notice of Intent contact activation pathway function blocking antibody AB023

The Defense Health Agency (DHA), Defense Health Agency Contracting Activity (DHACA), 808 Schreider Street, Fort Detrick, MD 21702, in support of the United States Army Institute of Surgical Research (USAISR) is issuing this notice of intent to procure items via Sole Source negotiation through the award of a contract to Oregon Health & Science University (OHSU). Under the contemplated award, Oregon Health & Science University, 3303 SW Bond Avenue, Portland, Oregon 97239, will provide contact activation pathway function blocking antibody AB023. Request for Information (RFI) HT9426-26-RFI-WS03 was posted on https://sam.gov from 12 June 2026 to 18 June 2026 with no responses received. The North American Industry Classification System (NAICS) for this requirement is 541714 with a size standard